Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection

The lung is a critical prophylaxis target for clinically important infectious agents, including human respiratory syncytial virus (RSV) and influenza. Here, we develop a modular, synthetic mRNA-based approach to express neutralizing antibodies directly in the lung via aerosol, to prevent RSV infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwari, Pooja Munnilal, Vanover, Daryll, Lindsay, Kevin E., Bawage, Swapnil Subhash, Kirschman, Jonathan L., Bhosle, Sushma, Lifland, Aaron W., Zurla, Chiara, Santangelo, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167369/
https://www.ncbi.nlm.nih.gov/pubmed/30275522
http://dx.doi.org/10.1038/s41467-018-06508-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167369/
https://www.ncbi.nlm.nih.gov/pubmed/30275522
http://dx.doi.org/10.1038/s41467-018-06508-3

Ejemplares similares